The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2018 / Oct / Embracing Technologies & Enhancing Outcomes
Manufacture Outsourcing Small Molecules Technology & Manufacturing Sponsored

Embracing Technologies & Enhancing Outcomes

Examining the hottest trends and techniques in drug development.

10/22/2018 1 min read

Sponsored By

Share

Experts from Johnson Matthey examine some of the hottest trends in drug development. With many new drugs suffering from poor solubility and bioavailability, Alan Chorlton discusses why solid state science is more important than ever before, while Paul Evans examines the innovator drugs today that will be tomorrow’s generic targets. Looking to the medicines of the future, Beatriz Dominguez and Ahir Pushpanath explain how enzyme engineering has opened up new possibilities in biocatalysis, and Kevin Hennessy looks at the growing interest in cannabinoid drug development. Finally, Nick Shackley gives his view on why outsourcing can help companies get the most from their molecules.

>> Download the PDF

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Video: Sitting Down With… Delara Motlagh
Cell & Gene Bioprocessing Outsourcing
Video: Sitting Down With… Delara Motlagh

November 13, 2026

1 min read

Fujifilm Cellular Dynamics’ Delara Motlagh discusses her path into cell and gene therapy, the challenges of scaling manufacturing, and the potential of iPSC technologies

Lonza to Acquire Five US CDMO Sites from Merck KGaA
Biopharma Bioprocessing Industry News
Lonza to Acquire Five US CDMO Sites from Merck KGaA

November 11, 2026

2 min read

The deal adds viral vector, bioconjugation, payload-linker, and advanced drug-delivery capabilities to Lonza’s manufacturing network

Strategic Development of Complex Oral Therapies
Formulation Small Molecules Development & Clinical
Strategic Development of Complex Oral Therapies

November 2, 2026

5 min read

Early characterization and manufacturing planning can help developers choose the right formulation strategy for complex oral therapies

Choosing a Sterile Fill-Finish Partner
Outsourcing
Choosing a Sterile Fill-Finish Partner

October 22, 2026

5 min read

Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: